143 related articles for article (PubMed ID: 21954056)
1. Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.
Walsh RA; Lang AE
Mov Disord; 2012 Feb; 27(2):326. PubMed ID: 21954056
[No Abstract] [Full Text] [Related]
2. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
[TBL] [Abstract][Full Text] [Related]
3. Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
Wilson L; Sheehan J; Thorpe M
Ir Med J; 2013 Jan; 106(1):24-5. PubMed ID: 23472375
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
[TBL] [Abstract][Full Text] [Related]
5. Is pathological gambling in Parkinson's disease reduced by amantadine?
Lee JY; Kim HJ; Jeon BS
Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095
[No Abstract] [Full Text] [Related]
6. [Impulse control disorders in Parkinson's disease].
Joutsa J; Kaasinen V
Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
[TBL] [Abstract][Full Text] [Related]
7. Drugs can trigger pathological gambling.
Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
[TBL] [Abstract][Full Text] [Related]
8. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH
Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118
[No Abstract] [Full Text] [Related]
9. Topiramate in managing impulse control disorders in Parkinson's disease.
Bermejo PE
Parkinsonism Relat Disord; 2008; 14(5):448-9. PubMed ID: 18339573
[No Abstract] [Full Text] [Related]
10. Amantadine-induced livedo reticularis: a report of two cases.
Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA
J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266
[TBL] [Abstract][Full Text] [Related]
11. Amantadine induced reversible corneal edema.
Deogaonkar M; Wilson K; Vitek J
J Clin Neurosci; 2011 Feb; 18(2):298-9. PubMed ID: 21163653
[TBL] [Abstract][Full Text] [Related]
12. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
13. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Weintraub D; Koester J; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Arch Neurol; 2010 May; 67(5):589-95. PubMed ID: 20457959
[TBL] [Abstract][Full Text] [Related]
14. Impulse control disorders and dopaminergic drugs.
Morgan JC; Iyer SS; Sethi KD
Arch Neurol; 2006 Feb; 63(2):298-9; author reply 299. PubMed ID: 16476826
[No Abstract] [Full Text] [Related]
15. Compulsive use of dopamine replacement therapy among Parkinson's disease patients: if it looks like a duck, swims like a duck and quacks like a duck..
Kaye S
Addiction; 2012 Feb; 107(2):251-3. PubMed ID: 22248134
[No Abstract] [Full Text] [Related]
16. Drug-induced delusions of parasitosis during treatment of Parkinson's disease.
Swick BL; Walling HW
J Am Acad Dermatol; 2005 Dec; 53(6):1086-7. PubMed ID: 16310077
[No Abstract] [Full Text] [Related]
17. Dropped head associated with amantadine in Parkinson disease.
Kataoka H; Ueno S
Clin Neuropharmacol; 2011; 34(1):48-9. PubMed ID: 21242745
[TBL] [Abstract][Full Text] [Related]
18. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
Kimber TE; Thompson PD; Kiley MA
J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
[TBL] [Abstract][Full Text] [Related]
19. Renaissance of amantadine in the treatment of Parkinson's disease.
Blanchet PJ; Metman LV; Chase TN
Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683
[No Abstract] [Full Text] [Related]
20. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
